LATE-BREAKING ABSTRACT: GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
The in vitro profile of ADC3680, a potent and selective CRTh2 antagonist for the treatment of inadequately controlled asthma Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
Enhanced anti-inflammatory gene expression in humans following inhaled budesonide Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
When needed use of inhaled steroids in children with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014
In vitro profile of the new inhaled pan-JAK inhibitor LAS194046Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
One-year coverage by inhaled steroids in asthma: French claims data Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
The inverse agonist propranolol does not confer steroid-sparing activity in persistent asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014
LATE-BREAKING ABSTRACT: Inhibition of the ubiquitin-E3-ligase FBXW7 enhances steroid efficacy: New concept for treating steroid insensitivity Source: International Congress 2015 – Asthma mechanisms and management Year: 2015
Biopharmaceutical and chemical compatibility of the combination of salbutamol hemisuccinate and methatropium iodide Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Pharmacological treatment of asthma today Source: Eur Respir J 2001; 18: 34S-40S Year: 2001
Anti-inflammatory effect of low dose theophylline in school children with bronchial asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? Source: Eur Respir J 2011; 38: 947-958 Year: 2011
Effect of inhaled beclomethasone or placebo on brain stem activity in a patient chronically treated with steroids - Preliminary report Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
LATE-BREAKING ABSTRACT: Anti-inflammatory effect of a novel inhaled dual PDE3/4 inhibitor RPL554 in man, a unique “first-in-class” drug for the treatment of COPD & asthma Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014
Chronic dosing effects of propranolol in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
Effect of treatment of drug resistant tuberculosis on thyroid stimulating hormone Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014